LINC02475

Across TCGA pan-cancer cohorts, LINC02475 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC02475 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02475 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02475 expression acts as an unfavorable survival marker, although some lineages such as SKCM and THYM show a favorable association.

BLCA, KIRC, and SKCM are the cancer types where LINC02475 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Quartile	IV	0.175	0.519	.002	57	view →
KIRC	DFS	Quartile	II,III,IV	0.346	0.659	<.001	55	view →
SKCM	OS	Tertile	II,III,IV	0.509	0.221	<.001	51	view →
HNSC	OS	Quartile	All	0.589	0.780	.011	29	view →
LIHC	OS	Quartile	All	0.383	0.589	.001	29	view →
CESC	OS	Tertile	II,III,IV	0.387	0.609	.025	24	view →
THYM	DFS	Tertile	All	0.950	0.788	.007	22	view →
STAD	DFS	Quartile	IV	0.172	0.879	.004	18	view →
UVM	DFS	Tertile	All	0.141	0.744	.024	18	view →
PAAD	OS	Median	All	0.682	0.495	.014	12	view →
ACC	DFS	Median	All	0.224	0.667	.001	12	view →
COAD	OS	Quartile	II,III,IV	0.246	0.712	.003	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC02475–BLCA (DFS)

Open the BLCA breakdown →